Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
31.98
+2.64 (9.00%)
Apr 29, 2026, 4:08 PM HKT

HKG:3378 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
614.4161.21162
Short-Term Investments
-12.6742.36
Trading Asset Securities
37.76--
Cash & Short-Term Investments
652.17173.88204.36
Cash Growth
275.07%-14.92%-
Prepaid Expenses
39.6668.9193.9
Other Current Assets
--0.5
Total Current Assets
691.83242.79298.76
Property, Plant & Equipment
19.9524.1324
Long-Term Investments
222.96233.78262.39
Other Intangible Assets
0.420.450.56
Other Long-Term Assets
0.330.330.53
Total Assets
935.48501.47586.24
Accounts Payable
18.8712.2912.94
Accrued Expenses
7.62.82.56
Short-Term Debt
10--
Current Portion of Long-Term Debt
20--
Current Portion of Leases
3.523.173.2
Current Income Taxes Payable
7.027.987.07
Other Current Liabilities
28.11171.237.11
Total Current Liabilities
95.11197.4462.87
Long-Term Debt
17--
Long-Term Leases
5.358.6611.83
Long-Term Deferred Tax Liabilities
70.478.7790.47
Other Long-Term Liabilities
--101.49
Total Liabilities
187.86284.87266.66
Common Stock
13.6211.799.53
Retained Earnings
--72.380.53
Comprehensive Income & Other
684.12226.83258.07
Total Common Equity
697.74166.24268.13
Minority Interest
49.8850.3751.45
Shareholders' Equity
747.62216.6319.58
Total Liabilities & Equity
935.48501.47586.24
Total Debt
55.8611.8315.03
Net Cash (Debt)
596.3162.05189.33
Net Cash Growth
267.98%-14.41%-
Net Cash Per Share
5.0414.8225.95
Filing Date Shares Outstanding
13.6211.797.3
Total Common Shares Outstanding
13.6211.797.3
Working Capital
596.7145.35235.89
Book Value Per Share
51.2214.1036.75
Tangible Book Value
697.32165.79267.57
Tangible Book Value Per Share
51.1914.0636.68
Machinery
-5.144.1
Construction In Progress
-2.666.41
Leasehold Improvements
-8.2-
Source: S&P Capital IQ. Standard template. Financial Sources.